tbuckley/cabot-search huggingface dataset:
Mutations in the Poly(A)-Specific Ribonuclease (PARN) Impair Telomerase RNA 3' End Maturation in Dyskeratosis Congenita Patients
Authors: Diane H. Moon, Matthew Segal, Baris Boyraz, Eva Guinan, Inga Hofmann, Patrick Cahan, Albert K Tai, Suneet Agarwal
Journal: Blood (2015)
Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT
Authors: Sebastian Giebel, Myriam Labopin, Adalberto Ibatici, Paul Browne, Tomasz Czerw, Gérard Socié, Ali Unal, Slawomira Kyrcz-Krzemien, Andrea Bacigalupo, Hakan Goker, Michael N Potter, Grant McQuaker, Dietrich Beelen, Noel Milpied, Antonio Campos, Charles Craddock, Mohamad Mohty
Journal: Blood (2013)
¿CUÁL ES LA FORMA MÁS EFICAZ DE REALIZAR UN TATUAJE ENDOSCÓPICO PARA LA POSTERIOR CIRUGÍA DE LESIONES COLORRECTALES? RESULTADOS INICIALES
Authors: D Barquero Declara, A Mata Bilbao, A Blasco Pelicano, M Navarro Llavat, A Bargalló García, A Fernández Simón, O García Bosch, M Martín Llahí, F Baños Massip, C Vasconez Peña
Journal: Endoscopy (2016)

Introducción: La identificación intraoperatoria de una lesión previamente detectada por endoscopia puede ser difícil. El tatuaje endoscópico facilita esta identificación, sin embargo, no existe evidencia científica en relación a cuál es la mejor técnica de tatuaje.
17 Lines About Chemo
Authors: Meredith L. Clements
Journal: JAMA Oncology (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Actual proportion of patients (pts) receiving chemotherapy or cetuximab for head and neck squamous carcinoma (HNSC)
Authors: J. J. Grau, M. Caballero, E. Verger, J. L. Blanch
Journal: Journal of Clinical Oncology (2009)

e17058 Background: With the new indications of chemotherapy or cetuximab in HNSC, the rate of pts receiving these therapies nowadays is unclear. Methods: This retrospective study identified all consecutive pts with HNSC from January 1, 2006, to December 31, 2007, presented in a multidisciplinary team to decide further treatment in a single institution. ASCO guidelines for larynx preservation were followed to select surgery or chemoradiotherapy (ChRt). We classified the intention-to-treat as palliative, adjuvant or induction therapy. In the last case, always with concomitant radiotherapy (Rt) or prior to concomitant ChRt. Cetuximab was indicated with Rt as induction therapy for pts with problems to receive platin-based chemotherapy. Results: : A total of 350 pts were identified, 320 were male (91%), and 30 female (9%), with mean age 60.4 (range 41–90). Primary tumor was located in glottis (41%), supraglottis (19%), hypopharynx (11%), oropharynx (20%), or mouth (9%). Staging was I (27%), II (22%), III (16%), or IV (35%). Surgery alone was performed in 136 pts (39%) and chemotherapy or cetuximab in 214 other pts (61%). The intention-to-treat was palliative in 69 (32%), adjuvant in 51 (24%), or induction 94(44%) of the pts respectively. Rt plus cetuximab was administered to 31/97 (33%) and Rt plus chemotherapy in 63/97 (67%) pts as induction therapy. During this 2-year period, some pts received both induction/adjuvant and palliative chemotherapy. Conclusions: Chemotherapy or cetuximab is indicated as part of treatment in more than a half of pts with HNSC. Induction therapy is the most frequent indication. No significant financial relationships to disclose.
Identification of Gene Expression Based Prognostic Markers in the Hematopoietic Stem Cells of Patients with Myelodysplastic Syndromes
Authors: Andrea Pellagatti, Axel Benner, Ken I Mills, Mario Cazzola, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G Della Porta, Martin Jadersten, Amit Verma, Emma-Jane McDonald, Sally Killick, Eva Hellstrom-Lindberg, Lars Bullinger, James S Wainscoat, Jacqueline Boultwood
Journal: Blood (2012)
EVENTOS GASTROINTESTINALES DESPUÉS DE UNA COLONOSCOPIA NORMAL EN UN PROGRAMA ORGANIZADO DE CRIBADO DE CÁNCER COLORRECTAL BASADO EN FIT
Authors: L Rivero-Sánchez, M Pellisé, M López-Cerón, J Grau, A Pozo, A Serradesanferm, JM Augé, L Llovet, A Castells
Journal: Endoscopy (2016)

Introducción: La prueba inmunoquímica de sangre oculta en heces positiva (FIT) se asocia a la presencia de neoplasia colorrectal y a lesiones sangrantes no neoplásicas. Sin embargo, una considerable proporción de individuos con FIT-positivo tienen una colonoscopia normal.
TCT-828 Very Late Vasomotor Responses and Gene Expression Profiles of Porcine Coronary Arteries at 4 Years after Deployment of the Everolimus-eluting Bioresorbable Vascular Scaffold and the Everolimus-eluting Metallic Xience V stent
Authors: Bill D. Gogas, None sandeep kumar, James Benham, Deepal Panchal, Yasir Bouchi, Olivia Hung, Rounak Gandhi, Nikolaos Spilias, Esha Singhal, Don P. Giddens, Alessandro Veneziani, Richard Rapoza, Spencer King, Hanjoong Jo, Habib Samady
Journal: Journal of the American College of Cardiology (2016)
TCT-555 Intravascular Ultrasound Guidance Improves the Long-term Prognosis in Patients with Unprotected Left Main Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Authors: Yida Tang, Jian Tian, Changdong Guan, Wenyao Wang, Kuo Zhang, Jue Chen, Yongjian Wu, Hongbing Yan, Yanyan Zhao, Shubin Qiao, Yuejin Yang, Gary Mintz, Bo Xu
Journal: Journal of the American College of Cardiology (2016)
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies
Authors: Changchun Deng, Mark R. Lipstein, Luigi Scotto, Xavier O. Jirau Serrano, Michael A. Mangone, Shirong Li, Jeremie Vendome, Yun Hao, Xiaoming Xu, Shi-Xian Deng, Ronald B. Realubit, Nicholas P. Tatonetti, Charles Karan, Suzanne Lentzsch, David A. Fruman, Barry Honig, Donald W. Landry, Owen A. O’Connor
Journal: Blood (2016)
The Level of Peroxiredoxin and Catalase On Single Cell Level Is Correlated with the Positivity of Ph Chromosome in the Bone Marrow of CML Patients During Imatinib Therapy.
Authors: Kyoung-Eun Lee, Hyun Ae Woo, Seung Ha Yang, Jung-Won Huh, Jee-Young Ahn, Soo Ah Oh, Yeung-Chul Mun, Eun-Sun Yoo, Eunmi Nam, Sue Goo Rhee, Chu-Myong Seong
Journal: Blood (2009)
TCT-417 Bioresorbable vascular scaffold in chronic total coronary artery occlusions: results from the RAI registry
Authors: Bruno Loi, Bernardo Cortese, Francesco Sanna, Giuseppe Tarantini, Alfonso Ielasi, Massimo Fineschi, Diego Calzolari, Gabriele Gabrielli, Alessandro Durante, Francesco Pisano, Attilio Varricchio, Luciano Moretti, Donatella Corrado, Giuseppe Steffenino
Journal: Journal of the American College of Cardiology (2016)
TCT-72 Short and medium-term clinical outcome of amphilimus polymer-free drug-eluting stent in diabetic patients: An all-comers multicenter spanish registry. (Control-8 registry)
Authors: Antonio Gomez Menchero, javier balaguer, Diego Lopez Otero, Rosa Maria Cardenal Piris, Mohsen Mohandes, Jose Guindo Soldevila, Abel Andres, Jessica Roa-Garrido, Silvia Siles, Ana Belen Cid Alvarez, Ramiro Trillo, Jose Francisco Diaz Fernandez
Journal: Journal of the American College of Cardiology (2016)
TCT-138 Multivessel versus culprit-only percutaneous coronary intervention in ST-segment elevation myocardial infarction: analysis of a 8 year-all-comers registry
Authors: Ana Belen Cid Alvarez, Carlos Galvao Braga, Alfredo Redondo Dieguez, Ramiro Trillo, Diego Lopez Otero, Raymundo Ocaranza-Sanchez, Belen Alvarez Alvarez, Kieran Docherty, Jose Ramon González-Juanatey
Journal: Journal of the American College of Cardiology (2016)
A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease
Authors: Fernando J. Martinez, David Mannino, Nancy Kline Leidy, Karen G. Malley, Elizabeth D. Bacci, R. Graham Barr, Russ P. Bowler, MeiLan K. Han, Julia F. Houfek, Barry Make, Catherine A. Meldrum, Stephen Rennard, Byron Thomashow, John Walsh, Barbara P. Yawn
Journal: American Journal of Respiratory and Critical Care Medicine (2016)

Chronic obstructive pulmonary disease (COPD) is often unrecognized and untreated.To develop a method for identifying undiagnosed COPD requiring treatment with currently available therapies (FEV1 <60% predicted and/or exacerbation risk).We conducted a multisite, cross-sectional, case-control study in U.S. pulmonary and primary care clinics that recruited subjects from primary care settings. Cases were patients with COPD and at least one exacerbation in the past year or FEV1 less than 60% of predicted without exacerbation in the past year. Control subjects were persons with no COPD or with mild COPD (FEV1 ≥60% predicted, no exacerbation in the past year). In random forests analyses, we identified the smallest set of questions plus peak expiratory flow (PEF) with optimal sensitivity (SN) and specificity (SP).PEF and spirometry were recorded in 186 cases and 160 control subjects. The mean (SD) age of the sample population was 62.7 (10.1) years; 55% were female; 86% were white; and 16% had never smoked. The mean FEV1 percent predicted for cases was 42.5% (14.2%); for control subjects, it was 82.5% (15.7%). A five-item questionnaire, CAPTURE (COPD Assessment in Primary Care to Identify Undiagnosed Respiratory Disease and Exacerbation Risk), was used to assess exposure, breathing problems, tiring easily, and acute respiratory illnesses. CAPTURE exhibited an SN of 95.7% and an SP of 44.4% for differentiating cases from all control subjects, and an SN of 95.7% and an SP of 67.8% for differentiating cases from no-COPD control subjects. The PEF (males, <350 L/min; females, <250 L/min) SN and SP were 88.0% and 77.5%, respectively, for differentiating cases from all control subjects, and they were 88.0% and 90.8%, respectively, for distinguishing cases from no-COPD control subjects. The CAPTURE plus PEF exhibited improved SN and SP for all cases versus all control subjects (89.7% and 78.1%, respectively) and for all cases versus no-COPD control subjects (89.7% and 93.1%, respectively).CAPTURE with PEF can identify patients with COPD who would benefit from currently available therapy and require further diagnostic evaluation. Clinical trial registered with clinicaltrials.gov (NCT01880177).
Dynamic contrast-enhanced MRI to predict response to vinorelbine–cisplatin alone or with rh-endostatin in patients with non-small cell lung cancer and bone metastases: a randomised, double-blind, placebo-controlled trial
Authors: Rui Zhang, Zhi-Yu Wang, Yue-Hua Li, Yao-Hong Lu, Shuai Wang, Wen-Xi Yu, Hui Zhao
Journal: The Lancet (2016)
TCT-558 Comparison of in-hospital outcome between intracoronary imaging-guided versus angiography-guided percutaneous coronary intervention in patient with acute myocardial infarction
Authors: Jun-Hyok Oh, Jeong cheon Choe, Jinhee Ahn, Park Jin Sup, Hye Won Lee, junghyun choi, Han Cheol Lee, Kwang Cha, Hong Taek-Jong
Journal: Journal of the American College of Cardiology (2016)
Effect of Polyglycolic Acid Mesh for Prevention of Pancreatic Fistula Following Distal Pancreatectomy
Authors: Jin-Young Jang, Yong Chan Shin, Youngmin Han, Joon Seong Park, Ho-Seong Han, Ho Kyoung Hwang, Dong Sup Yoon, Jae Keun Kim, Yoo Seok Yoon, Dae Wook Hwang, Chang Moo Kang, Woo Jung Lee, Jin Seok Heo, Mee Joo Kang, Ye Rim Chang, Jihoon Chang, Woohyun Jung, Sun-Whe Kim
Journal: JAMA Surgery (2016)

The rate of postoperative pancreatic fistula (POPF) after distal pancreatectomy ranges from 13% to 64%. To prevent POPF, polyglycolic acid (PGA) mesh was introduced, but its effect has been evaluated only in small numbers of patients and retrospective studies.To evaluate the efficacy of PGA mesh in preventing POPF after distal pancreatectomy.Prospective randomized clinical, single-blind (participant), parallel-group trial at 5 centers between November 2011 and April 2014. The pancreatic parenchyma was divided using a stapling device; no patient was given prophylactic octreotide. Perioperative and clinical outcomes were compared including POPF, which was graded according to the criteria of the International Study Group For Pancreatic Fistulas. A total of 97 patients aged 20 to 85 years with curable benign, premalignant, or malignant disease of the pancreatic body or tail were enrolled (44 in the PGA group and 53 in the control group).Patients in the PGA group underwent transection of the pancreas and application of fibrin glue followed by wrapping the PGA mesh around the remnant pancreatic stump.The primary end point of this study was the development of a clinically relevant POPF (grade B or C by the International Study Group grading system). The secondary end point was the evaluation of risk factors for POPF.The study therefore evaluated a total of 97 patients, 44 in the PGA group and 53 in the control group. Thirty-nine patients were women and 58 patients were men. There were no differences in mean (SD) age (59.9 [12.0] years vs 54.5 [14.1] years, P = .05), male to female ratio (1.0:1.3 vs 1.0:1.7, P = .59), malignancy (40.9% vs 32.1%, P = .37), mean (SD) pancreatic duct diameter (1.92 [0.75] mm vs 1.94 [0.95] mm, P = .47), soft pancreatic texture (90.9% vs 83.0%, P = .17), and mean (SD) thickness of the transection margin (16.9 [5.4] mm vs 16.4 [4.9] mm, P = .63) between the PGA and control groups. The rate of clinically relevant POPF (grade B or C) was significantly lower in the PGA group than in the control group (11.4% vs 28.3%, P = .04).Wrapping of the cut surface of the pancreas with PGA mesh is associated with a significantly reduced rate of clinically relevant POPF.clinicaltrials.gov Identifier: NCT01550406.
Pruritic Waxy and Verrucous Papules in a Middle-Aged Man
Authors: Jason C. Sluzevich, Paul M. Hoesly
Journal: JAMA Dermatology (2016)

A man in his 60s had skin-colored, waxy, smooth and variably verrucous papules and plaques on the nose and hands refractory to topical corticosteroid treatment; he had photosensitivity as a boy and no blistering, angioedema, dysphagia, hoarseness, dyspnea, or weight loss. What is your diagnosis?
Intensive Timed Sequential Chemotherapy Followed by a Single Pegfilgrastim (Neulasta) Administration in Patients with High-Risk Acute Myeloid Leukemia (AML): Preliminary Results of the EMA-2000/Neu Trial.
Authors: Xavier Thomas, Youcef Chelghoum, Anne Thiebaut, Mohamed Elhamri, Emmanuelle Tavernier, Nabaz Jaff, Quoc-Hung Le, Mauricette Michallet
Journal: Blood (2006)
Phase II Study of the Frontline Hyper-CVAD in Combination with Ofatumumab for Adult Patients (pts) with CD-20 Positive Acute Lymphoblastic Leukemia (ALL)
Authors: Koji Sasaki, Paul B. Koller, Hagop M. Kantarjian, Deborah A Thomas, Maria R. Khouri, Guillermo Garcia-Manero, Rebecca Garris, Jorge E. Cortes, Heather Schroeder, Jad Chahoud, Tapan Kadia, Farhad Ravandi, Srdan Verstovsek, Naval Daver, Nitin Jain, Marina Konopleva, Susan O'Brien, Elias Jabbour
Journal: Blood (2015)
TCT-166 Correlates and Prognostic Impact of New-Onset Heart Failure after ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Insights from the INFUSE-AMI Trial
Authors: Gennaro Giustino, Bjorn Redfors, Sorin Brener, Ajay Kirtane, Philippe Généreux, Akiko Maehara, Dariusz Dudek, Thomas Neunteufl, D. Christopher Metzger, Roxana Mehran, C. Michael Gibson, Gregg Stone
Journal: Journal of the American College of Cardiology (2016)
TCT-260 Outcomes of Chronic Total Occlusion PCI in Patients with Diabetes – Insights from the OPEN CTO Registry
Authors: Adam Salisbury, James Sapontis, J. Aaron Grantham, Mohammed Qintar, Kensey Gosch, William Lombardi, Dimitrios Karmpaliotis, Jeffrey Moses, John Spertus, David Cohen, Mikhail Kosiborod
Journal: Journal of the American College of Cardiology (2016)
Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival
Authors: Cecilia G. Ethun, Lauren M. Postlewait, Nina Le, Timothy M. Pawlik, Stefan Buettner, George Poultsides, Thuy Tran, Kamran Idrees, Chelsea A. Isom, Ryan C. Fields, Linda X. Jin, Sharon M. Weber, Ahmed Salem, Robert C. G. Martin, Charles Scoggins, Perry Shen, Harveshp D. Mogal, Carl Schmidt, Eliza Beal, Ioannis Hatzaras, Rivfka Shenoy, David A. Kooby, Shishir K. Maithel
Journal: JAMA Surgery (2016)

<h3>Importance</h3> The current recommendation is to perform re-resection for select patients with incidentally discovered gallbladder cancer. The optimal time interval for re-resection for both patient selection and long-term survival is not known. <h3>Objective</h3> To assess the association of time interval from the initial cholecystectomy to reoperation with overall survival. <h3>Design, Setting, and Participants</h3> This cohort study was conducted from January 1, 2000, to December 31, 2014 at 10 US academic institutions. A total of 207 patients with incidentally discovered gallbladder cancer who underwent reoperation and had available data on the date of their initial cholecystectomy were included. <h3>Exposures</h3> Time interval from the initial cholecystectomy to reoperation: group A: less than 4 weeks; group B: 4 to 8 weeks; and group C: greater than 8 weeks. <h3>Main Outcomes and Measures</h3> Primary outcome was overall survival. <h3>Results</h3> Of 449 patients with gallbladder cancer, 207 cases (46%) were discovered incidentally and underwent reoperation at 3 different time intervals from the date of the original cholecystectomy: group A: less than 4 weeks (25 patients, 12%); B: 4 to 8 weeks (91 patients, 44%); C: more than 8 weeks (91 patients, 44%). The mean (SD) ages of patients in groups A, B, and C were 65 (9), 64 (11), and 66 (12) years, respectively. All groups were similar for baseline demographics, extent of resection, presence of residual disease, T stage, resection margin status, lymph node involvement, and postoperative complications. Patients who underwent reoperation between 4 and 8 weeks had the longest median overall survival (group B: 40.4 months) compared with those who underwent early (group A: 17.4 months) or late (group C: 22.4 months) reoperation (log-rank<i>P</i> = .03). Group A and C time intervals (vs group B), presence of residual disease, an R2 resection, advanced T stage, and lymph node involvement were associated with decreased overall survival on univariable Cox regression. Only group A (hazard ratio, 2.63; 95% CI, 1.25-5.54) and group C (hazard ratio, 2.07; 95% CI, 1.17-3.66) time intervals (vs group B), R2 resection (hazard ratio, 2.69; 95% CI, 1.27-5.69), and advanced Tstage (hazard ratio, 1.85; 95% CI, 1.11-3.08) persisted on multivariable Cox regression analysis. <h3>Conclusions and Relevance</h3> The optimal time interval for re-resection for incidentally discovered gallbladder cancer appears to be between 4 and 8 weeks after the initial cholecystectomy.
A QUANTITATIVE THEORY OF THE PRECIPITIN REACTION
Authors: Michael Heidelberger, Forrest E. Kendall
Journal: The Journal of Experimental Medicine (1935)

1. A quantitative theory of the precipitin reaction based on the laws of classical chemistry has been tested on an azoprotein-antiprotein system and found to apply. 2. With its aid relationships may be deduced which permit the calculation of the behavior of an antidye serum over its entire range after a few quantitative chemical analyses have been made for antigen and antibody in the precipitate. 3. An empirical relation is also presented which further reduces the number of analyses necessary. 4. A study of supernatants in the inhibition zone has shown that the entire amount of dissolved antigen-antibody compound present is precipitated when supernatants are analyzed for antigen by the precipitin method.
Patient–physician trust in China: a workshop summary
Authors: Cheris S C Chan, Yu Cheng, Yali Cong, Zhizheng Du, Shanlian Hu, Amanda Kerrigan, Arthur Kleinman, Mengfeng Li, Benjamin Liebman, Yonghui Ma, Jing-Bao Nie, Daniel F C Tsai, Duujian Tsai, Joseph D Tucker, Lijie Wang, Bonnie Wong, William C W Wong, Zeping Xiao, Juncai Xu, Yunxiang Yan, Yang Yang, Daqing Zhang, Mingjie Zhao, Jianfeng Zhu, Wei Zhu
Journal: The Lancet (2016)
EFICACIA DE LA COLOCACIÓN DE PRÓTESIS METÁLICAS AUTOEXPANDIBLES CUBIERTAS EN EL MANEJO DE PATOLOGÍA BENIGNA ESOFÁGICA
Authors: J Carrascosa Gil, A Pueyo Royo, JF Juanmartiñena Fernández, C Saldaña Dueñas, A Zúñiga Ripa, I Fernández-Urién Sainz, E Albéniz Arbizu, J Eguaras Ros, JJ Vila Costas
Journal: Endoscopy (2016)

Históricamente, la colocación de prótesis esofágicas se limitaba a pacientes con disfagia secundaria a cáncer, con intención paliativa. En los últimos años su uso se ha extendido al manejo de patología benigna.
TCT-518 The Interaction between Aortic and Coronary Pressures for Fractional Flow Reserve Value in Patients with an Intermediate Coronary Artery Stenosis
Authors: Hiroyuki Okura, Yuhei Kobayashi, Yoji Neishi, Tomitaka Higa, Yukari Kobayashi, Shiro Uemura, Kiyoshi Yoshida
Journal: Journal of the American College of Cardiology (2016)
Case 17-1979
Authors: Richard C. Cabot, Robert E. Scully, James J. Galdabini, Betty U. McNeely, Lloyd Axelrod, Austin L. Vickery
Journal: New England Journal of Medicine (1979)

Presentation of CaseA 71-year-old woman was admitted to the hospital because of recurrent bouts of stupor and coma.She was well until 10 years previously, when she became confused while driving an automobile. She entered another hospital, where mild hyperglycemia was noted, and she was placed on a diabetic diet. Five years before admission a second episode of confusion occurred. Evaluation at another hospital revealed hypothyroidism, and thyroid hormone was prescribed. One year later insulin was begun. Three years before admission she again became confused and was brought back to the hospital, where she recovered her orientation after two . . .
PS01.62: Long-Term Safety and Clinical Activity of Atezolizumab Monotherapy in Metastatic NSCLC: Final Results from a Phase Ia Study
Authors: Michael S. Gordon, Roy S. Herbst, Leora Horn, Jean-Charles Soria, Leena Gandhi, Enriqueta Felip, Lecia Sequist, David R. Spigel, Scott J. Antonia, Ani Balmanoukian, Philippe Cassier, Bo Liu, Marcin Kowanetz, Carol O'Hear, Marcella Fassò, Alan Sandler, Scott N. Gettinger
Journal: Journal of Thoracic Oncology (2016)
TCT-382 Temporal Trends in Incidence and Outcomes of Acute Kidney Injury Complicating Peripheral Vascular Interventions in the United States
Authors: Sahil Khera, Tanush Gupta, Dhaval Kolte, Wilbert Aronow, Hasan Ahmad, Gregg Fonarow, Douglas Drachman, Deepak Bhatt
Journal: Journal of the American College of Cardiology (2016)
TCT-421 In Vivo Serial Assessment of Coronary Vessel Geometry Restoration and Resorption Process Following the Implantation of Second-Generation Drug-Eluting Absorbable Metal Scaffold (DREAMS 2G): Insights from the BIOSOLVE-II First-In-Man Trial
Authors: Hector Manel Garcia-Garcia, Michael Haude, Hüseyin Ince, Alexandre Abizaid, Ralph Toelg, Pedro Lemos, Clemens von Birgelen, Evald Christiansen, William Wijns, Franz-Josef Neumann, Christoph Kaiser, Eric Eeckhout, Soo Teik Lim, Javier Escaned, Ron Waksman
Journal: Journal of the American College of Cardiology (2016)